CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Symbio Pharmaceuticals Ltd Company Snapshot
Symbio Pharmaceuticals Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Symbio Pharmaceuticals Ltd with three other companies in this sector in JAPAN : Carna Biosciences Inc (2019 sales of 3.21 billion Japanese Yen [US$30.79 million] of which 66% was Drug Discovery Business), Peptidream Inc (2.07 billion Japanese Yen [US$19.92 million] of which 100% was Alliance), and Japan Tissue Engineering Company Limited (2.36 billion Japanese Yen [US$22.64 million] of which 60% was Regenerative Medicine Products Business).

Sales Analysis. Symbio Pharmaceuticals Ltd reported sales of ¥2.84 billion (US$27.24 million) for the year ending December of 2019. This represents a sharp decrease of 26.0% versus 2018, when the company's sales were ¥3.84 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Symbio Pharmaceuticals Ltd
  Stock Performance Chart for Symbio Pharmaceuticals Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/27/2020): 387.00
(Figures in Japanese Yen )
1 Week 3.2%   13 Weeks 13.2%  
4 Weeks -3.3%   52 Weeks -39.6%  
 
Symbio Pharmaceuticals Ltd Key Data:
  Ticker: 4582 Country: Japan
  Exchanges: TYO JSQ Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 2,837,753,000
(Year Ending Jan 2020).
Employees: 107
  Currency: Japanese Yen Market Cap: 13,611,481,956
  Fiscal Yr Ends: December Shares Outstanding: 35,171,788
  Share Type: Common Closely Held Shares: 3,217,400
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.